Browse by Journal Title

2024

Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree, B.A.C., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., She, D., Rees, W., Smith, M., Cimbora, D., Katz, E. and Bennett, J.L.
Lancet Neurology 23 (6): 588-602. June 2024

2023

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
Banwell, B., Bennett, J.L., Marignier, R., Kim, H.J., Brilot, F., Flanagan, E.P., Ramanathan, S., Waters, P., Tenembaum, S., Graves, J.S., Chitnis, T., Brandt, A.U., Hemingway, C., Neuteboom, R., Pandit, L., Reindl, M., Saiz, A., Sato, D.K., Rostasy, K., Paul, F., Pittock, S.J., Fujihara, K. and Palace, J.
Lancet Neurology 22 (3): 268-282. March 2023

2022

Diagnosis and classification of optic neuritis.
Petzold, A., Fraser, C.L., Abegg, M., Alroughani, R., Alshowaeir, D., Alvarenga, R., Andris, C., Asgari, N., Barnett, Y., Battistella, R., Behbehani, R., Berger, T., Bikbov, M.M., Biotti, D., Biousse, V., Boschi, A., Brazdil, M., Brezhnev, A., Calabresi, P.A., Cordonnier, M., Costello, F., Cruz, F.M., Cunha, L.P., Daoudi, S., Deschamps, R., de Seze, J., Diem, R., Etemadifar, M., Flores-Rivera, J., Fonseca, P., Frederiksen, J., Frohman, E., Frohman, T., Tilikete, C.F., Fujihara, K., Gálvez, A., Gouider, R., Gracia, F., Grigoriadis, N., Guajardo, J.M., Habek, M., Hawlina, M., Martínez-Lapiscina, E.H., Hooker, J., Hor, J.Y., Howlett, W., Huang-Link, Y., Idrissova, Z., Illes, Z., Jancic, J., Jindahra, P., Karussis, D., Kerty, E., Kim, H.J., Lagrèze, W., Leocani, L., Levin, N., Liskova, P., Liu, Y., Maiga, Y., Marignier, R., McGuigan, C., Meira, D., Merle, H., Monteiro, M.L.R., Moodley, A., Moura, F., Muñoz, S., Mustafa, S., Nakashima, I., Noval, S., Oehninger, C., Ogun, O., Omoti, A., Pandit, L., Paul, F., Rebolleda, G., Reddel, S., Rejdak, K., Rejdak, R., Rodriguez-Morales, A.J., Rougier, M.B., Sa, M.J., Sanchez-Dalmau, B., Saylor, D., Shatriah, I., Siva, A., Stiebel-Kalish, H., Szatmary, G., Ta, L., Tenembaum, S., Tran, H., Trufanov, Y., van Pesch, V., Wang, A.G., Wattjes, M.P., Willoughby, E., Zakaria, M., Zvornicanin, J., Balcer, L. and Plant, G.T.
Lancet Neurology 21 (12): 1120-1134. December 2022

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley, J.F., Defer, G., Ryerson, L.Z., Cohen, J.A., Arnold, D.L., Butzkueven, H., Cutter, G., Giovannoni, G., Killestein, J., Wiendl, H., Smirnakis, K., Xiao, S., Kong, G., Kuhelj, R. and Campbell, N.
Lancet Neurology 21 (7): 608-619. July 2022

2021

Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Marignier, R., Hacohen, Y., Cobo-Calvo, A., Pröbstel, A.K., Aktas, O., Alexopoulos, H., Amato, M.P., Asgari, N., Banwell, B., Bennett, J., Brilot, F., Capobianco, M., Chitnis, T., Ciccarelli, O., Deiva, K., De Sèze, J., Fujihara, K., Jacob, A., Kim, H.J., Kleiter, I., Lassmann, H., Leite, M.I., Linington, C., Meinl, E., Palace, J., Paul, F., Petzold, A., Pittock, S., Reindl, M., Sato, D.K., Selmaj, K., Siva, A., Stankoff, B., Tintore, M., Traboulsee, A., Waters, P., Waubant, E., Weinshenker, B., Derfuss, T., Vukusic, S. and Hemmer, B.
Lancet Neurology 20 (9): 762-772. September 2021

2020

Monogenic variants in dystonia: an exome-wide sequencing study.
Zech, M., Jech, R., Boesch, S., Škorvánek, M., Weber, S., Wagner, M., Zhao, C., Jochim, A., Necpál, J., Dincer, Y., Vill, K., Distelmaier, F., Stoklosa, M., Krenn, M., Grunwald, S., Bock-Bierbaum, T., Fečíková, A., Havránková, P., Roth, J., Příhodová, I., Adamovičová, M., Ulmanová, O., Bechyně, K., Danhofer, P., Veselý, B., Haň, V., Pavelekova, P., Gdovinová, Z., Mantel, T., Meindl, T., Sitzberger, A., Schröder, S., Blaschek, A., Roser, T., Bonfert, M.V., Haberlandt, E., Plecko, B., Leineweber, B., Berweck, S., Herberhold, T., Langguth, B., Švantnerová, J., Minár, M., Ramos-Rivera, G.A., Wojcik, M.H., Pajusalu, S., Õunap, K., Schatz, U.A., Pölsler, L., Milenkovic, I., Laccone, F., Pilshofer, V., Colombo, R., Patzer, S., Iuso, A., Vera, J., Troncoso, M., Fang, F., Prokisch, H., Wilbert, F., Eckenweiler, M., Graf, E., Westphal, D.S., Riedhammer, K.M., Brunet, T., Alhaddad, B., Berutti, R., Strom, T.M., Hecht, M., Baumann, M., Wolf, M., Telegrafi, A., Person, R.E., Zamora, F.M., Henderson, L.B., Weise, D., Musacchio, T., Volkmann, J., Szuto, A., Becker, J., Cremer, K., Sycha, T., Zimprich, F., Kraus, V., Makowski, C., Gonzalez-Alegre, P., Bardakjian, T.M., Ozelius, L.J., Vetro, A., Guerrini, R., Maier, E., Borggraefe, I., Kuster, A., Wortmann, S.B., Hackenberg, A., Steinfeld, R., Assmann, B., Staufner, C., Opladen, T., Růžička, E., Cohn, R.D., Dyment, D., Chung, W.K., Engels, H., Ceballos-Baumann, A., Ploski, R., Daumke, O., Haslinger, B., Mall, V., Oexle, K. and Winkelmann, J.
Lancet Neurology 19 (11): 908-918. November 2020

2019

Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial.
Levin, J., Maaß, S., Schuberth, M., Giese, A., Oertel, W.H., Poewe, W., Trenkwalder, C., Wenning, G.K., Mansmann, U., Südmeyer, M., Eggert, K., Mollenhauer, B., Lipp, A., Löhle, M., Classen, J., Münchau, A., Kassubek, J., Gandor, F., Berg, D., Egert-Schwender, S., Eberhardt, C., Paul, F., Bötzel, K., Ertl-Wagner, B., Huppertz, H.J., Ricard, I. and Höglinger, G.U.
Lancet Neurology 18 (8): 724-735. August 2019

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ciccarelli, O., Cohen, J.A., Reingold, S.C. and Weinshenker, B.G.
Lancet Neurology 18 (2): 185-197. February 2019

2018

Rare coding variants in genes encoding GABA A receptors in genetic generalised epilepsies: an exome-based case-control study.
May, P., Girard, S., Harrer, M., Bobbili, D.R., Schubert, J., Wolking, S., Becker, F., Lachance-Touchette, P., Meloche, C., Gravel, M., Niturad, C.E., Knaus, J., De Kovel, C., Toliat, M., Polvi, A., Iacomino, M., Guerrero-López, R., Baulac, S., Marini, C., Thiele, H., Altmüller, J., Jabbari, K., Ruppert, A.K., Jurkowski, W., Lal, D., Rusconi, R., Cestèle, S., Terragni, B., Coombs, I.D., Reid, C.A., Striano, P., Caglayan, H., Siren, A., Everett, K., Møller, R.S., Hjalgrim, H., Muhle, H., Helbig, I., Kunz, W.S., Weber, Y.G., Weckhuysen, S., Jonghe, P.D., Sisodiya, S.M., Nabbout, R., Franceschetti, S., Coppola, A., Vari, M.S., Kasteleijn-Nolst Trenité, D., Baykan, B., Ozbek, U., Bebek, N., Klein, K.M., Rosenow, F., Nguyen, D.K., Dubeau, F., Carmant, L., Lortie, A., Desbiens, R., Clément, J.F., Cieuta-Walti, C., Sills, G.J., Auce, P., Francis, B., Johnson, M.R., Marson, A.G., Berghuis, B., Sander, J.W., Avbersek, A., McCormack, M., Cavalleri, G.L., Delanty, N., Depondt, C., Krenn, M., Zimprich, F., Peter, S., Nikanorova, M., Kraaij, R., van Rooij, J., Balling, R., Ikram, M.A., Uitterlinden, A.G., Avanzini, G., Schorge, S., Petrou, S., Mantegazza, M., Sander, T., LeGuern, E., Serratosa, J.M., Koeleman, B.P.C., Palotie, A., Lehesjoki, A.E., Nothnagel, M., Nürnberg, P., Maljevic, S., Zara, F., Cossette, P., Krause, R. and Lerche, H.
Lancet Neurology 17 (8): 699-708. August 2018

2017

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
Petzold, A., Balcer, L.J., Calabresi, P.A., Costello, F., Frohman, T.C., Frohman, E.M., Martinez-Lapiscina, E.H., Green, A.J., Kardon, R., Outteryck, O., Paul, F., Schippling, S., Vermersch, P., Villoslada, P. and Balk, L.J.
Lancet Neurology 16 (10): 797-812. October 2017

2016

What is the future of proof of concept studies in multiple sclerosis?
Paul, F.
Lancet Neurology 15 (11): 1107-1109. October 2016

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Martinez-Lapiscina, E.H., Arnow, S., Wilson, J.A., Saidha, S., Preiningerova, J.L., Oberwahrenbrock, T., Brandt, A.U., Pablo, L.E., Guerrieri, S., Gonzalez, I., Outteryck, O., Mueller, A.K., Albrecht, P., Chan, W., Lukas, S., Balk, L.J., Fraser, C., Frederiksen, J.L., Resto, J., Frohman, T., Cordano, C., Zubizarreta, I., Andorra, M., Sanchez-Dalmau, B., Saiz, A., Bermel, R., Klistorner, A., Petzold, A., Schippling, S., Costello, F., Aktas, O., Vermersch, P., Oreja-Guevara, C., Comi, G., Leocani, L., Garcia-Martin, E., Paul, F., Havrdova, E., Frohman, E., Balcer, L.J., Green, A.J., Calabresi, P.A. and Villoslada, P.
Lancet Neurology 15 (6): 574-584. May 2016

2013

From mice to man: chloride transport in leukoencephalopathy.
Jentsch, T.J.
Lancet Neurology 12 (7): 626-628. July 2013

2012

Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study.
Rosewich, H., Thiele, H., Ohlenbusch, A., Maschke, U., Altmüller, J., Frommolt, P., Zirn, B., Ebinger, F., Siemes, H., Nürnberg, P., Brockmann, K. and Gärtner, J.
Lancet Neurology 11 (9): 764-73. September 2012

2011

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.
Barthel, H., Gertz, H.J., Dresel, S., Peters, O., Bartenstein, P., Buerger, K., Hiemeyer, F., Wittemer-Rump, S.M., Seibyl, J., Reininger, C. and Sabri, O.
Lancet Neurology 10 (5): 424-435. May 2011

2008

Treatment-resistant chronic headaches and focal pachymeningitis in a 46-year-old man: a rare presentation of Wegener's granulomatosis.
Doerr, J., Elitok, S., Dieste, F.J., Vogel, H.P., Schneider, W., Wuerfel, J., Zipp, F. and Paul, F.
Lancet Neurology 7 (4): 368-372. April 2008